Monographie - Infliximab - Stabilis 4.0

Viimeisin päivitys :
19/11/2024

Immunosupressiiviset lääkkeet

Infliximab

Injektioneste

Silmätipat

Stabilius liuoksessa

Stabilius seoksissa

Tekijät, jotka vaikuttavat stabiliuteen

Yhteensopivuus

Antotapa

Viitteet

pdf

Kauppanimi

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Flixabi	Belgia, Espanja, Iso-Britannia, Saksa
Flixceli	Marokko
Inflectra	Belgia, Espanja, Islanti, Iso-Britannia, Italia, Kanada, Romania, Saksa, Sveitsi
Infliximab	Chile
Remicade	Argentiina, Australia, Belgia, Chile, Ecuador, Espanja, Hollanti, Iran, Irlanti, Islanti, Iso-Britannia, Italia, Itävalta, Japani, Kanada, Kolumbia, Kreikka, Luxemburg, Malesia, Marokko, Meksiko, New Zealand, Norja, Portugali, Puola, Ranska, Romania, Ruotsi, Saksa, Saudi-Arabia, Suomi, Sveitsi, Tanska, Tunisia, Turkki, Venezuela, Yhdistyneet arabiemiirikunnat, Yhdysvallat
Remsima	Argentiina, Belgia, Chile, Ecuador, Espanja, Islanti, Iso-Britannia, Italia, Kanada, Marokko, Norja, Ranska, Romania, Saksa, Sveitsi, Turkki
Zessli	Belgia, Iso-Britannia, Saksa

Viitteet

Injektioneste

Viitteet : Infliximab

	tyyppi	julkaisu
754	Laboratorio	Infliximab (Remicade®) – Summary of Product Characteristics Merck Sharp & Dohme 2019
2296	Laboratorio	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
3137	Lehti	Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS. Infliximab stability after reconstitution, dilution, and storage under refrigeration. Retina 2010 ; 30, 1: 81-84.
3317	ilmoitus	Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. Stabilité de l'infliximab en solutions diluées. APHIF Congress 2009
3333	Lehti	Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M. Stability of infliximab in polyvinyl chloride bags. Am J Health-Syst Pharm 2012 ; 69:1509-1512.
3825	Lehti	Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G. Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance. J Pharm Pract and Res 2015 ; 496: 421-431.
3924	Lehti	Vieillard V, Astier A, Sauzay C, Paul M. One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Ann Pharm Fr 2016 ; 75, 1 : 17-29.
4003	Lehti	Kim J, Chung J, Park S, Jung S, Kang D. Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). EJHP 2017 ; 25, 3: 157-164.
4049	Lehti	Tokhadze N, Chennell P, Le Basle Y, Sautou V. Stability of infliximab solutions in different temperature and dilution conditions. J Pharm Biomed Anal 2018 ; 150 : 386-395
4279	Lehti	Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Bio Drugs 2019 ; 33: 193–205.
4292	Lehti	Vimpolsek M, Gottar-Guillier M, Rossy E. Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. Drugs R D 2019 19: 127–140.

Mentions Légales